Bioidentical Hormone Replacement Therapy (BHRT):

An introductory guide for prescribers.

A CME-certified educational webinar introducing frameworks for evaluating, initiating and managing bioidentical hormone therapy in practice.

Live Webinar | July 28, 2026 | 10:00AM-11:15AM PST / 1:00PM-2:15PM EST
$99 per registrant
1.25 AMA PRA Category 1 Credit(s)™

A faded Shield Valor Logo back image behind the main imagePhoto of doctor crossing their arms

Webinar Overview

Walk away with practical knowledge on patient selection and dosing protocols.
Understand the clinical evidence supporting bioidentical hormone replacement therapy in your practice.
15 minutes of Q&A at the end of the webinar.

Learning Objectives:

After attending this webinar, participants will be able to:

  • Explain the role of hormone health in midlife care and itsimpact on patient quality of life.​
  • Differentiate compounded BHRT from FDA-approvedhormone therapies in terms of regulation and use.​
  • Review foundational principles of hormone physiology relevant to BHRT
  • Compare commonly utilized bioidentical hormone formulations
  • Describe practical implementation considerations in clinical practice
  • Describe foundational concepts of compounded BHRT, including formulation and customization.​
  • Apply evidence-based principles to clinical decision-making when prescribing compounded BHRT.​
  • Identify clinical factors when evaluating potential candidates
  • Discuss monitoring strategies and documentation considerations
icon of clipboard with heart on it

Describe the key endogenous hormone pathways relevant to menopausal and perimenopausal care.

See how proper prescribing improves quality of life for your patients.

icon of a notepad with hex-cell shapes on it

Differentiate compounded bioidentical hormone therapy from FDA-approved hormone therapy with respect to evidence, regulatory status, and clinical considerations.

Master the protocols that keep your patients safe while achieving therapeutic goals.

icon of medical leaflet with information in it

Summarize the current regulatory landscape governing hormone therapy and compounded preparations.

Examine actual cases and ask our specialists your toughest questions.

icon of person in a pharmacy or healthcare building

Interpret relevant laboratory testing to inform individualized hormone therapy decisions.

Examine actual cases and ask our specialists your toughest questions.

icon of pill on computer screen

Evaluate when compounded hormone formulations are clinically appropriate, applying the same evidentiary standards used for commercially available products.

Examine actual cases and ask our specialists your toughest questions.

1.25 AMA PRA Category 1 Credit(s)™

Speaker Biography

Christine Stephanos, RPh, BCSCP
VP & Chief Pharmacy Officer
VP & Chief Pharmacy Officer
Certified Master in HRT
Our speaker today brings a truly exceptional depth of experience to the world of pharmacy and compounding. 

She holds a Bachelor of Science in Pharmacy from the Faculty of Pharmacy at Alexandria University and is certified in Sterile Compounding Techniques through the University of Florida. She carries additional certifications in sterile and non-sterile compounding from PCCA, PCAB, and Medisca, and is a licensed and registered pharmacist in the state of California.
Christine Stephanos, Vice President & Chief Pharmacy Officer at Valor

This introductory webinar is designed for:

Physicians, Physician Associates, Nurse Practitioners, and other healthcare professionals interested in bioidentical hormone replacement therapy.

Accreditation Statement

CME Outfitters Logo

In support of improving patient care, this activity has been planned and implemented by Valor Compounding Pharmacy and CME Outfitters, LLC. CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CME Outfitters, LLC designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Disclosures
Christine Stephanos, RPh, BCSCP, has nothing to disclose.

Planning Committee Disclosures 
Daniela Jones, Marie Judkins, Shari Tordoff and Imman Rathore have nothing to disclose.

Unlabeled Use Disclosure 
Faculty of this CME/CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices. CME Outfitters, LLC, the faculty, and Valor Compounding Pharmacy do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use. 
*All relevant financial relationships have been mitigated.

This educational activity is intended for licensed healthcare professionals. Content is for educational purposes only and does not constitute medical, legal, or regulatory advice. Clinical decisions should be made based on independent professional judgment and applicable laws and guidelines.
Disclaimer: This educational activity is intended for licensed healthcare professionals. Content is for educational purposes only and does not constitute medical, legal, or regulatory advice. Clinical decisions should be made based on independent professional judgment and applicable laws and guidelines.